very rarely comparable. The aims of this paper are to list the existing population-based registers of acute myocardial infarction (AMI) and stroke in Europe, describe their methodology, and discuss their comparability. Methods: using a questionnaire a comprehensive and updated picture on available sources of information, data, indicators, and methods were collected for population-based registers. The information requested generally included: the studied disease; the scope of the study (geographical area, temporal duration, age range, population); adopted methodologies (case definition, ICD coding for mortality and hospital discharge records, linkage and validation methods); morbidity indicators (attack rate, incidence, prevalence, case fatality rate). Results: Belgium, Denmark, Finland, France, Germany, Italy, Norway, Spain, and Sweden have ongoing population-based registers for AMI. Denmark, Finland, France, Germany, Italy, Norway, and Sweden have ongoing population-based registers for stroke. Selection procedures of events, differences in age range, different validation procedures and methods make the results from these registers difficult to compare. Conclusions: Population-based registers provide the best indicators for AMI and stroke, such as attack rate and case fatality. Registers cover large samples of the population, usually regions or large municipalities. The comparability of data across countries depends on standardization, case definition, completeness, proper linkage, common diagnostic criteria and validation procedures. Given the high burden of AMI and stroke, efforts are needed in implementing registers in all European countries.
The EUROCISS Project (European Cardiovascular Indicators Surveillance Set) started in 2000 thanks to a partnership of European Union (EU) countries to develop health indicators and recommendations for the monitoring of cardiovascular diseases (CVD). It is part of the Health Monitoring Programme financed by the European Commission. 1 The aims of the EUROCISS project are to identify, among existing data sets, the essential information required to objectively define morbidity indicators for CVD and to recommend standardized methods for future monitoring of CVD and data collection in the EU. This would permit cross-country comparisons to improve the prevention and control of CVD, to set public health priorities and determine appropriate actions. For acute myocardial infarction (AMI) and stroke, CVDs of major interest, the most useful indicator is an attack rate, which considers first and recurrent events and is based on a combination of mortality and morbidity data. Attack rates may be derived from population-based registers. National registers utilizing administrative data from hospital discharges and deaths have existed for many years in the Nordic countries. [2] [3] [4] [5] Many countries of the EU have participated in the MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Diseases), which was a multicentre study involving formation of population-based registers. It produced valid and reliable information on fatal and non-fatal acute coronary and cerebrovascular events in different populations during the years 1985-1994. 6,7 Attack rates produced by MONICA have been useful for cross-country comparisons of acute coronary and cerebrovascular trends in men and women. Information on mortality and morbidity was compiled using consistent methodology and validation techniques, applying standardized diagnostic criteria to identify events over time. The methodology, however, was very expensive, the population under surveillance was limited to persons aged 35-64 years and the selected areas were not necessarily representative of the whole country. Following the MONICA experience, other simplified surveillance systems were set up in some EU countries. 9, 10 The purpose of EUROCISS has been to produce an inventory of different sources of information with available data on AMI and stroke in order to evaluate the best and most easily accessible indicators and to develop recommendations for assessing the burden of CVDs. We quickly discovered that morbidity data are rarely available in the different countries and, when available, they are very rarely comparable. The aim of this paper is to list the existing population-based AMI and stroke registers in Europe and to describe their methodology in order to discuss their comparability.
MATERIALS AND METHODS
To obtain a comprehensive and updated picture on available CVD morbidity data, the partner countries of the project completed a questionnaire. The purpose of the questionnaire was to collect data necessary for making the inventory of the main sources of information, available data, indicators, and methods. The questionnaire included five forms concerning the following main sources of information: population-based registers, hospital discharge records, surveys, longitudinal studies and GP-networks. We requested that the information provided be as accurate and detailed as possible. We were aware that each country might have developed different types of research and information sources, and thus partners were asked to choose those they judged the most complete and representative of their own country, in order to offer the best information at a national or regional level. In particular we asked to identify the ongoing populationbased registers, which collected information on fatal and non-fatal events in and out of hospital. Information derived from the completed questionnaires on AMI and stroke registers has been summarized. All of the information collected will constitute the basis for achieving the last aim of EUROCISS, the 'recommendations for the collection of comparable data for monitoring the CVD morbidity in the European Union'.
RESULTS

Acute myocardial infarction
Information on AMI registers is reported in table 1. Registers are available at regional level in Belgium, 11 Denmark, 12 Finland, 2,10,13 France, 14 Germany, 15 Italy, 16, 17 Norway, Spain 18 and Sweden. 4, 19 Most of the registers started between the second half of the 1980s and the first half of the 1990s (Finland, France, Germany, Italy-MONICA, Spain and Sweden), while others are more recent (Belgium-Bruges, Italy and Norway). The ages covered range between 25 and 74 years or more. Many of these registers adopt simplified methodologies derived from the MONICA Project, using a record linkage of AMI from hospital discharge register and mortality and validating the suspected events by applying the MONICA diagnostic criteria. 20 In several Health status indicators represent a set of surveillance data properly adopted to assess the health status of the population. A standardized definition of disease is crucial for this process. Indicators can be used to set public health priorities and determine appropriate actions. Selection of indicators should be based on existing and comparable data sets for which regular monitoring is feasible. Indicators also need to be comprehensive, valid (sensitive and specific), standardized, and meet quality criteria. On the basis of these considerations, population-based registers provide the best source of information for AMI and stroke data. In fact they are usually built taking into account mortality and hospital discharge data related to fatal and non-fatal events. They provide indicators such as attack rate and case fatality. Attack rate includes first and recurrent event and case fatality in and out of hospital. Incidence can be assessed if information on first event is available. If survival rates are available, prevalence can also be assessed. 17, 40 Registers often cover representative areas of the population, usually regions or large municipalities. National registers of AMI have been also compiled utilizing administrative data from hospital discharges and deaths; these registers are economical, include all age groups and collect large numbers of events. However, they are not planned for scientific research, data are not collected by standardized methods, and quality control procedures are limited. The comparability of data across countries depends on standardization, case definition, completeness, proper linkage, common diagnostic criteria and validation procedures. In particular data inaccuracy may represent a problem for stroke: 50% of 'new stroke diagnoses' are merely sequelae of an old stroke. This problem increases with age. 3, 33, 34, 37 A unique identification number for each subject would be very useful for linkage procedures between hospital discharge diagnosis and death certificate records. The identification of events can be done by 'hot pursuit' or 'cold pursuit'. Hot pursuit means identifying case admissions to the hospital, usually within one or two days from the event onset, and acquiring relevant information by visiting the ward or interviewing the patient. Information bias is minimized by the 'hot pursuit' approach, as information is collected immediately after the event. 8, 41 However, the process is expensive. 'Cold pursuit' implies the use of routine and delayed procedures, hospital discharge and death records. The process is easier and less expensive than hot pursuit; the number of cases studied is smaller because discharge diagnoses are more precise and specific than those on admission but there is the possibility of missing important information. Both methods are used to identify suspected events, which must be validated applying standardized criteria. Several European countries have registers for AMI and stroke. The high cost of registers limits their implementation at a national level; therefore they should be established in representative areas of a country (regions, macro-areas, etc.). A simplified method, based on a record linkage of hospital discharge diagnoses and death certificates, with validation of a sample of events according to standardized diagnostic criteria, as adopted in many countries, might be suggested for those countries which do not have registers. This method uses sources of information and databases currently available in public health services, and aims to identify the number of fatal and non-fatal major coronary and cerebrovascular events; the positive predictive value, in such registers can be determined from comparisons with standardized validation systems such as MONICA. 16 The possibility of linking routinely collected data may be improved through a unique identification number as in the Nordic countries. It is advisable for those countries that do not have registers to establish them following standardized procedures and using the experiences of the other countries. This would permit cross-country comparisons to improve the prevention and control of CVDs. The EUROCISS group has observed that no population data or registries are currently available in Europe on HF. Given the high burden of this form of CVD, further efforts to obtain information on HF are needed and the possibility of implementing registries needs to be considered.
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